Brett Hamer is an experienced commercial leader with over a decade in the global sports nutrition industry. His career spans a diverse range of markets and business models, with a proven track record of driving growth through strategic product development, omni-channel execution, and international licensing.
With deep expertise across the full product lifecycle, Brett has successfully led the development and launch of high-performing nutrition products across retail, e-commerce, and distribution channels. His ability to align commercial strategy with consumer insight has enabled him to deliver sustained results in both mature and emerging markets.
Brett’s global experience includes managing cross-functional teams and projects across the UK, Europe, North America, and Asia. This international perspective has equipped him with a strong understanding of regulatory frameworks, market dynamics, and cultural nuances essential to successful brand expansion.
Sara is a demand generation expert with over 20 years of experience across the FMCG, retail, and consulting sectors. She currently leads the Strategic Demand function for Mars Europe, overseeing category management, strategic revenue management, and portfolio activation. Before her current role, she headed the Strategy function for Mars Food, driving growth initiatives and long-term business transformation.
Drawing on her broad cross-industry background, Sara brings an holistic perspective on how innovation, strategic foresight, and consumer understanding can shape resilient and future-ready portfolios. At Mars, she champions the company’s commitment to quality ingredients, sustainability, and trust — key pillars in building the portfolio of tomorrow.
Ms. Ferrari is Vice President of Clinical Operations at Curis. Ms. Ferrari is an end-to-end drug development professional with twenty years of biotech industry experience. Previously, she led program management and clinical operations at Aileron Therapeutics as Vice President, Clinical Development and Program Management. Earlier, Ms. Ferrari had a lengthy tenure at ArQule, working in positions of increasing responsibilities within clinical operations and clinical development in both oncology and rare disease. While at ArQule, Ms. Ferrari was responsible for leading programs from pre-IND through all stages of clinical development. Of note, Ms. Ferrari led the development team responsible for ArQule’s BTK program from IND enabling through early-stage clinical operations leading to the acquisition of ArQule by Merck. Prior to ArQule, Ms. Ferrari worked at Ziopharm Oncology and Epix Pharmaceuticals where she was part of the team leading to the FDA approval of Vasovist. She earned her Bachelor of Science degree from the University of Massachusetts, Amherst.
Jenny is Head of our A&A and Compliance division and oversees our file review service, technical queries, manuals and all of our A&A training. Jenny is passionate about quality and ensures all of our A&A and Compliance products and services are technically sound and fit for purpose. Jenny has worked for Mercia for over 12 years and has held many positions within the A&A team including, Head of Manuals, Team Lead File Reviews and a lecturer.
Jenny sits on the ICAEW ISA Panel, which closely tracks and inputs into IAASB developments and its work programme. It focuses on the development of new and proposed revisions to auditing and assurance standards and contributes to the development of ICAEW policy on relevant audit and assurance matters. In order to stay practical at Mercia, Jenny performs file reviews and occasionally lectures.
Before joining Mercia, Jenny was an Audit Manager with Deloitte in their Nottingham office where she was involved in a range of clients from small owner managed businesses through to large listed international businesses and this covered providing audit, accounts and advisory services.
Jenny spends most of her time out of work looking after her young family and lively dog.
Over 20 years of experience in the biopharmaceutical industry with focus on Clinical Program Management, Clinical Operations, and International Regulatory Affairs spanning from early clinical development though marketing application preparation and commercial activities.
Cameron has a unique blend of industry experience and knowledge. He spent 23 years of his career building & forging alliances and pursuing new business for notable public and private sector players such as Menarini Pharmaceuticals, AstraZeneca, University of Dundee/NHS Tayside, Synexus, and industry-leading CROs such as Covance Inc. (Labcorp R&D) and ICON plc.
Melissa has 23 years of industry experience dedicated to accelerating patient recruitment from all possible feeds including site EHRs, AI and data enabled recruitment channels, digital and online media and community engagement programs. Melissa works to harness the benefits of applying innovative solutions toward successful patient recruitment and retention campaigns while driving health literacy, diversity and inclusion and patient access equity to reduce study burden and facilitate enrollment into everyday life. Melissa heads up Fortrea’s Voice of Patient program to drive patient insights into every step of the drug development paradigm and is a Co-Lead of Fortrea’s Site Advisory Board.
JK has over 20 years of experience in the pharmaceutical and CRO industries, with a strong background in strategic delivery. During that time, John has worked in pre-clinical toxicology, clinical pharmacology, first-in-human trials, digital health, site collaboration, patient recruitment, safety and pharmacovigilance, regulatory submission, market access and HEOR strategy, RWE, LTFU and phase IV studies, working across a range of tactics including ghost writing, podcasting, video production, strategy development and product launch.
